drugset
drugset / Trial / NCT05730621

A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

NCT05730621 ↗

Phase 4 Completed 68 enrolled Yuhan Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to compare the effects of sarpogrelate sustained release /aspirin combination therapy versus aspirin on blood viscosity in the patients with peripheral arterial disease and coronary artery disease

Timeline

Start
2023-01-11
Primary completion
2024-02-28
Completion
2024-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg —
Subject Sarpogrelate Small molecule 300 mg —

Indications

coronary artery disorder peripheral arterial disease